Brief: Qualigen Therapeutics Acquires Majority Stake In Infectious Disease Diagnostics Technology Company Nanosynex
02/06/2022 14:05
June 2 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS ACQUIRES MAJORITY STAKE IN
INFECTIOUS
DISEASE DIAGNOSTICS TECHNOLOGY COMPANY NANOSYNEX
Source text for Eikon: ID:nGNXbJmv8x
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise